Circulating IL-17 reduces the risk of cisplatin-induced hearing loss in children: a bidirectional two-sample Mendelian randomization study

Studies have reported that cytokines and their related signaling pathways play a role in inner ear diseases. In clinical practice, approximately 50% of pediatric cancer patients experience irreversible hearing loss after cisplatin treatment. However, currently, there is a lack of systematic research...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ying, Huang, Caijuan, Liu, Jingjing, Xu, Yaying, Yang, Haiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622445/
https://www.ncbi.nlm.nih.gov/pubmed/37919361
http://dx.doi.org/10.1038/s41598-023-46299-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622445/
https://www.ncbi.nlm.nih.gov/pubmed/37919361
http://dx.doi.org/10.1038/s41598-023-46299-2

Ejemplares similares